News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine – ESMO
Vivek Subbiah/LinkedIn
Mar 5, 2025, 07:35

The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine – ESMO

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

“ESMOTAT25: The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine.

Vivek Subbiah, MD discusses the paradigm shift away, at least partially, from organ-based treatment to molecularly guided treatment across tumour types. He describes how regulatory shifts and greater access to tumour profiling are now needed to realise their full benefits for patients.

To learn more, read the Opinion piece in the ESMO Daily Reporter.”

The transformative odyssey of Tumour Agnostic Drug Development in Precision Medicine - ESMO

More posts featuring ESMO.

cancer ESMO ESMO Daily Reporter ESMOTAT25 European Society for Medical Oncology OncoDaily Oncology Precision Medicine Tumour Agnostic Drug Development Vivek Subbiah
Special Coverage
Science
May 26, 2025, 18:57
Arndt Vogel: NEOPAN Shows PFS Benefit but No OS Gain with FOLFIRINOX in Locally Advanced PDAC
Science
May 26, 2025, 18:47
Saadvik Raghuram Y: A Randomized Trial of Afatinib vs Chemotherapy in NSCLC
Blog
May 26, 2025, 18:32
Stanley Wabomba: AORTIC-Africa Tailors Networking Side Event at ASCO 2025 to Meet Global Cancer Experts
Science
May 26, 2025, 18:05
Ashish Kamat: Molecular Profiling of 99 Cases of Micropapillary Urothelial Carcinoma
Blog
May 26, 2025, 17:55
Nasser Altorki presents a bold perspective at ESTS 2025 - European Society of Thoracic Surgeons
Blog
May 26, 2025, 17:13
Conquer Cancer, the ASCO Foundation Announces This Year’s Class of Conquer Cancer Grant and Award Recipients
Insight
May 26, 2025, 17:10
Priyamvada Maitre: Is RT and ADT Good Enough in PSMA-Staged High-Risk Prostate Cancer?
Science
May 26, 2025, 16:27
Myeloma Paper of the Day, May 26th, suggested by Robert Orlowski
Blog
May 26, 2025, 16:02
Oscar Tahuahua: China Overtook the U.S. in Cancer Research Output in 2014
Blog
May 26, 2025, 15:55
Farina Arreguin: Chemo-Immunotherapy Has Improved the Care of Patients With Relapsed/Refractory Neuroblastoma
Blog
May 26, 2025, 15:47
Miriam Mutebi: Across Africa, Women Are Transforming Surgical Care — One Patient, One Scalpel, One Breakthrough at a Time
Blog
May 26, 2025, 15:37
Supriya Peshin Announces Poster Acceptance on Colorectal Cancer at ESMO